{"created":"2023-05-15T14:54:19.781714+00:00","id":73835,"links":{},"metadata":{"_buckets":{"deposit":"38a40f49-eb4e-4e5f-b2ef-ec2c654da832"},"_deposit":{"created_by":1,"id":"73835","owners":[1],"pid":{"revision_id":0,"type":"depid","value":"73835"},"status":"published"},"_oai":{"id":"oai:repo.qst.go.jp:00073835","sets":["1"]},"author_link":["759683","759682","759687","759688","759684","759685","759686"],"item_8_biblio_info_7":{"attribute_name":"書誌情報","attribute_value_mlt":[{"bibliographicIssueDates":{"bibliographicIssueDate":"2018-06","bibliographicIssueDateType":"Issued"},"bibliographicIssueNumber":"3","bibliographicPageEnd":"848","bibliographicPageStart":"840","bibliographicVolumeNumber":"288","bibliographic_titles":[{"bibliographic_title":"Radiology"}]}]},"item_8_description_5":{"attribute_name":"抄録","attribute_value_mlt":[{"subitem_description":"Purpose To investigate the time-course changes and predictive utility of brain metabolite concentrations in neonatal hypoxic-ischemic encephalopathy (HIE). Materials and Methods Sixty-eight neonates (age, 35-41 gestational weeks) with HIE were admitted to a neonatal intensive care unit between September 2009 and March 2016 and examined by using proton MR spectroscopy at 18-96 hours (n = 25) and 7-14 days (n = 64) after birth (35-43 postmenstrual weeks) to estimate metabolite concentrations in the deep gray matter. Adverse outcome was defined as death or neurodevelopmental impairment at 18-22 months of age. Areas under the receiver operating characteristic curves were calculated to evaluate the prognostic values of metabolites. Results At 18-96 hours, N-acetylaspartate and creatine concentrations were lower, whereas lactate, and glutamate and glutamine (Glx) concentrations were higher in neonates with adverse outcomes than in those with favorable outcomes. Metabolite concentrations at 18-96 hours decreased during days 7-14 in neonates with adverse outcomes but did not change in those with favorable outcomes. For N-acetylaspartate, creatine, lactate, and Glx concentrations measured at 18-96 hours to predict adverse outcomes, areas under the receiver operating characteristic curve were 0.98, 0.89, 0.96, and 0.88, respectively, whereas at 7-14 days, the areas under the receiver operating characteristic curve were 0.97, 0.97, 0.59, and 0.36, respectively. Conclusion Time-dependent reductions in N-acetylaspartate and creatine concentrations at both 18-96 hours and 7-14 days accurately predicted adverse outcomes. However, higher lactate and glutamate and glutamine concentrations were often transient.","subitem_description_type":"Abstract"}]},"item_8_publisher_8":{"attribute_name":"出版者","attribute_value_mlt":[{"subitem_publisher":"Radiological Society of North America"}]},"item_8_relation_13":{"attribute_name":"PubMed番号","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"29893645","subitem_relation_type_select":"PMID"}}]},"item_8_relation_14":{"attribute_name":"DOI","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"10.1148/radiol.2018172083","subitem_relation_type_select":"DOI"}}]},"item_8_relation_17":{"attribute_name":"関連サイト","attribute_value_mlt":[{"subitem_relation_type_id":{"subitem_relation_type_id_text":"https://pubs.rsna.org/doi/10.1148/radiol.2018172083","subitem_relation_type_select":"URI"}}]},"item_8_source_id_9":{"attribute_name":"ISSN","attribute_value_mlt":[{"subitem_source_identifier":"0033-8419","subitem_source_identifier_type":"ISSN"}]},"item_access_right":{"attribute_name":"アクセス権","attribute_value_mlt":[{"subitem_access_right":"metadata only access","subitem_access_right_uri":"http://purl.org/coar/access_right/c_14cb"}]},"item_creator":{"attribute_name":"著者","attribute_type":"creator","attribute_value_mlt":[{"creatorNames":[{"creatorName":"Shibasaki, Jun"}],"nameIdentifiers":[{"nameIdentifier":"759682","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Aida, Noriko"}],"nameIdentifiers":[{"nameIdentifier":"759683","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Morisaki, Naho"}],"nameIdentifiers":[{"nameIdentifier":"759684","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tomiyasu, Moyoko"}],"nameIdentifiers":[{"nameIdentifier":"759685","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Nishi, Yuri"}],"nameIdentifiers":[{"nameIdentifier":"759686","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Toyoshima, Katsuaki"}],"nameIdentifiers":[{"nameIdentifier":"759687","nameIdentifierScheme":"WEKO"}]},{"creatorNames":[{"creatorName":"Tomiyasu, Moyoko","creatorNameLang":"en"}],"nameIdentifiers":[{"nameIdentifier":"759688","nameIdentifierScheme":"WEKO"}]}]},"item_language":{"attribute_name":"言語","attribute_value_mlt":[{"subitem_language":"eng"}]},"item_resource_type":{"attribute_name":"資源タイプ","attribute_value_mlt":[{"resourcetype":"journal article","resourceuri":"http://purl.org/coar/resource_type/c_6501"}]},"item_title":"Changes in Brain Metabolite Concentrations after Neonatal Hypoxic-ischemic Encephalopathy.","item_titles":{"attribute_name":"タイトル","attribute_value_mlt":[{"subitem_title":"Changes in Brain Metabolite Concentrations after Neonatal Hypoxic-ischemic Encephalopathy."}]},"item_type_id":"8","owner":"1","path":["1"],"pubdate":{"attribute_name":"公開日","attribute_value":"2019-02-25"},"publish_date":"2019-02-25","publish_status":"0","recid":"73835","relation_version_is_last":true,"title":["Changes in Brain Metabolite Concentrations after Neonatal Hypoxic-ischemic Encephalopathy."],"weko_creator_id":"1","weko_shared_id":-1},"updated":"2023-05-16T00:44:37.577473+00:00"}